title: Intrapulmonary shunting associated with sildenafil treatment in a patient with idiopathic pulmonary arterial hypertension.
authors.forename: Pablo F
authors.initials: PF
authors.lastname: Castro
authors.forename: Douglas
authors.initials: D
authors.lastname: Greig
authors.forename: Hugo E
authors.initials: HE
authors.lastname: Verdejo
authors.forename: Iván
authors.initials: I
authors.lastname: Godoy
authors.forename: Samuel
authors.initials: S
authors.lastname: Córdova
authors.forename: Marcela P
authors.initials: MP
authors.lastname: Ferrada
authors.forename: Robert C
authors.initials: RC
authors.lastname: Bourge
mesh_terms: D000328:Adult; D003287:Contrast Media; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology; D003937:Diagnosis, Differential; D004452:Echocardiography; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D000860:Hypoxia / Q000139:chemically induced*; D008297:Male; D010879:Piperazines / Q000009:adverse effects*; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology; D011659:Pulmonary Gas Exchange; D011687:Purines / Q000009:adverse effects; D000068677:Sildenafil Citrate; D012965:Sodium Chloride; D013450:Sulfones / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D014665:Vasodilator Agents / Q000009:adverse effects*
chemical_list: D003287:Contrast Media; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D012965:Sodium Chloride; D000068677:Sildenafil Citrate